...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Investigation on the isoform selectivity of histone deacetylase inhibitors using chemical feature based pharmacophore and docking approaches.
【24h】

Investigation on the isoform selectivity of histone deacetylase inhibitors using chemical feature based pharmacophore and docking approaches.

机译:使用基于化学特征的药效团和对接方法研究组蛋白脱乙酰基酶抑制剂的同工型选择性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A three dimensional (3D) chemical feature based pharmacophore model was developed for selective histone deacetylase 1 (HDAC1) inhibitors, which provides an efficient way to discuss the isoform selectivity of HDAC inhibitors. In contrast to the classical pan-HDAC pharmacophore, two hydrophobic features (HY and HYAr2) were found in the chemical feature based pharmacophore model, which might be responsible for the selectivity of HDAC1 inhibitions. Molecular docking also highlighted the two hydrophobic features, which are located in the internal cavity adjacent to the active site. The results contribute to our understanding of the molecular mechanism underlying the selectivity of HDAC1 inhibitors and suggest a possible target region to design novel selective HDAC1 inhibitors.
机译:为选择性组蛋白脱乙酰基酶1(HDAC1)抑制剂开发了基于三维(3D)化学特征的药效团模型,它提供了一种有效的方法来讨论HDAC抑制剂的同工型选择性。与经典的pan-HDAC药效团相比,在基于化学特征的药效团模型中发现了两个疏水性特征(HY和HYAr2),这可能是对HDAC1抑制作用的选择性。分子对接还突出了两个疏水性特征,它们位于内腔中与活性部位相邻的位置。结果有助于我们对HDAC1抑制剂选择性的分子机制的理解,并为设计新型选择性HDAC1抑制剂提供了可能的靶区域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号